As an official journal of the British Society for Immunology, Immunotherapy Advances aims to support the development of the next generation of immunologists. With this in mind, Immunotherapy Advances has developed a dedicated Editorial Board specifically for early career researchers (ECRs). The ECR Board members will join the editorial team of our brand new Open Access journal, develop their skills as peer reviewers, learn more about the editorial process and contribute to the growth and development of the journal.
The ECR Board members will work closely with more senior members of the Editorial Board to learn how to effectively review for a journal, as well as receiving experience in other Editorial Board activities. We hope that the ECR Board members will provide a fresh perspective on Immunotherapy Advances, supporting the journal's growth and offering ideas and opinions on future developments.
After calling for applications from ambitious and talented ECRs, we are delighted to announce the twelve new ECR Editorial Board members. Thank you to everyone who submitted an application.
(L–R) Dr Rebecca Chukwuanukwu (Nnamdi Azikiwe University, Nigeria); Dr Daniel Johnston (University College Dublin, Ireland); Dr Mark Robinson (Maynooth University, Ireland); Dr Elizabeth Mann (University of Oxford, UK)
(L–R) Dr Caroline Weight (University College London, UK); Dr Malcolm Sim (National Institute of Allergy and Infectious Diseases, USA); Dr Akhilesh Jha (University of Cambridge, UK); Dr Kirsten Ward-Hartstonge (University of Otago, New Zealand)
(L–R) Dr Eda Tenorio (Universidad Nacional Autónoma de México, Mexico); Dr Alsya Affandi (Amsterdam UMC, Netherlands); Dr Diana Cortes-Selva (Purdue University, USA); Dr Oskar Staufer (Max Planck Institute for Medical Research, Germany)
FIND OUT MORE
- Visit the official Immunotherapy Advances website
- Join the conversation online by following @IMTadvances on Twitter
- Find out more about the global Editorial Board
Immunotherapy Advances is an official journal of the British Society for Immunology. We’d like to encourage BSI members to support your Society’s first fully Open Access journal and submit your work.
We’re proud to offer a 20% discount on publication fees in Immunotherapy Advances for BSI members. All BSI members are eligible for a discounted Article Processing Charge (APC) of £1,600.